984 related articles for article (PubMed ID: 26076170)
1. R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.
Korvatska O; Leverenz JB; Jayadev S; McMillan P; Kurtz I; Guo X; Rumbaugh M; Matsushita M; Girirajan S; Dorschner MO; Kiianitsa K; Yu CE; Brkanac Z; Garden GA; Raskind WH; Bird TD
JAMA Neurol; 2015 Aug; 72(8):920-7. PubMed ID: 26076170
[TBL] [Abstract][Full Text] [Related]
2. Frontobasal gray matter loss is associated with the TREM2 p.R47H variant.
Luis EO; Ortega-Cubero S; Lamet I; Razquin C; Cruchaga C; Benitez BA; Lorenzo E; Irigoyen J; ; Pastor MA; Pastor P
Neurobiol Aging; 2014 Dec; 35(12):2681-2690. PubMed ID: 25027412
[TBL] [Abstract][Full Text] [Related]
3. Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains.
Ma L; Allen M; Sakae N; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Younkin SG; Sevlever D
Mol Neurodegener; 2016 Nov; 11(1):72. PubMed ID: 27887626
[TBL] [Abstract][Full Text] [Related]
4. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia.
Ruiz A; Dols-Icardo O; Bullido MJ; Pastor P; Rodríguez-Rodríguez E; López de Munain A; de Pancorbo MM; Pérez-Tur J; Alvarez V; Antonell A; López-Arrieta J; Hernández I; Tárraga L; Boada M; Lleó A; Blesa R; Frank-García A; Sastre I; Razquin C; Ortega-Cubero S; Lorenzo E; Sánchez-Juan P; Combarros O; Moreno F; Gorostidi A; Elcoroaristizabal X; Baquero M; Coto E; Sánchez-Valle R; Clarimón J;
Neurobiol Aging; 2014 Feb; 35(2):444.e1-4. PubMed ID: 24041969
[TBL] [Abstract][Full Text] [Related]
5. Differential splicing of neuronal genes in a Trem2*R47H mouse model mimics alterations associated with Alzheimer's disease.
Pandey RS; Kotredes KP; Sasner M; Howell GR; Carter GW
BMC Genomics; 2023 Apr; 24(1):172. PubMed ID: 37016304
[TBL] [Abstract][Full Text] [Related]
6. Triggering Receptor Expressed on Myeloid Cell 2 R47H Exacerbates Immune Response in Alzheimer's Disease Brain.
Korvatska O; Kiianitsa K; Ratushny A; Matsushita M; Beeman N; Chien WM; Satoh JI; Dorschner MO; Keene CD; Bammler TK; Bird TD; Raskind WH
Front Immunol; 2020; 11():559342. PubMed ID: 33101276
[TBL] [Abstract][Full Text] [Related]
7. R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia.
Slattery CF; Beck JA; Harper L; Adamson G; Abdi Z; Uphill J; Campbell T; Druyeh R; Mahoney CJ; Rohrer JD; Kenny J; Lowe J; Leung KK; Barnes J; Clegg SL; Blair M; Nicholas JM; Guerreiro RJ; Rowe JB; Ponto C; Zerr I; Kretzschmar H; Gambetti P; Crutch SJ; Warren JD; Rossor MN; Fox NC; Collinge J; Schott JM; Mead S
Alzheimers Dement; 2014 Nov; 10(6):602-608.e4. PubMed ID: 25160042
[TBL] [Abstract][Full Text] [Related]
8. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge.
Cousins O; Schubert JJ; Chandra A; Veronese M; Valkimadi P; Creese B; Khan Z; Arathimos R; Hampshire A; Rosenzweig I; Ballard C; Corbett A; Aasland D; Velayudhan L; O'Neill M; Collier D; Awais R; Sander K; Årstad E; Howes O; Turkheimer F; Hodges A
J Neuroinflammation; 2023 Nov; 20(1):272. PubMed ID: 37990275
[TBL] [Abstract][Full Text] [Related]
9. Coding variants in TREM2 increase risk for Alzheimer's disease.
Jin SC; Benitez BA; Karch CM; Cooper B; Skorupa T; Carrell D; Norton JB; Hsu S; Harari O; Cai Y; Bertelsen S; Goate AM; Cruchaga C
Hum Mol Genet; 2014 Nov; 23(21):5838-46. PubMed ID: 24899047
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes.
Thelen M; Razquin C; Hernández I; Gorostidi A; Sánchez-Valle R; Ortega-Cubero S; Wolfsgruber S; Drichel D; Fliessbach K; Duenkel T; Damian M; Heilmann S; Slotosch A; Lennarz M; Seijo-Martínez M; Rene R; Kornhuber J; Peters O; Luckhaus C; Jahn H; Hüll M; Rüther E; Wiltfang J; Lorenzo E; Gascon J; Lleó A; Lladó A; Campdelacreu J; Moreno F; Ahmadzadehfar H; ; Fortea J; Indakoetxea B; Heneka MT; Wetter A; Pastor MA; Riverol M; Becker T; Frölich L; Tárraga L; Boada M; Wagner M; Jessen F; Maier W; Clarimón J; López de Munain A; Ruiz A; Pastor P; Ramirez A
Neurobiol Aging; 2014 Nov; 35(11):2657.e13-2657.e19. PubMed ID: 25042114
[TBL] [Abstract][Full Text] [Related]
11. TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.
Pottier C; Wallon D; Rousseau S; Rovelet-Lecrux A; Richard AC; Rollin-Sillaire A; Frebourg T; Campion D; Hannequin D
J Alzheimers Dis; 2013; 35(1):45-9. PubMed ID: 23380991
[TBL] [Abstract][Full Text] [Related]
12.
Durmanova V; Javor J; Parnicka Z; Minarik G; Ocenasova A; Vaseckova B; Kiralyova I; Sutovsky S; Petrovic R; Shawkatova I
J Integr Neurosci; 2022 Jun; 21(4):105. PubMed ID: 35864757
[TBL] [Abstract][Full Text] [Related]
13. The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans.
Xiang X; Piers TM; Wefers B; Zhu K; Mallach A; Brunner B; Kleinberger G; Song W; Colonna M; Herms J; Wurst W; Pocock JM; Haass C
Mol Neurodegener; 2018 Sep; 13(1):49. PubMed ID: 30185230
[TBL] [Abstract][Full Text] [Related]
14. TREM2 variants in Alzheimer's disease.
Guerreiro R; Wojtas A; Bras J; Carrasquillo M; Rogaeva E; Majounie E; Cruchaga C; Sassi C; Kauwe JS; Younkin S; Hazrati L; Collinge J; Pocock J; Lashley T; Williams J; Lambert JC; Amouyel P; Goate A; Rademakers R; Morgan K; Powell J; St George-Hyslop P; Singleton A; Hardy J;
N Engl J Med; 2013 Jan; 368(2):117-27. PubMed ID: 23150934
[TBL] [Abstract][Full Text] [Related]
15. TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis.
Cady J; Koval ED; Benitez BA; Zaidman C; Jockel-Balsarotti J; Allred P; Baloh RH; Ravits J; Simpson E; Appel SH; Pestronk A; Goate AM; Miller TM; Cruchaga C; Harms MB
JAMA Neurol; 2014 Apr; 71(4):449-53. PubMed ID: 24535663
[TBL] [Abstract][Full Text] [Related]
16. The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer's disease.
Cheng-Hathaway PJ; Reed-Geaghan EG; Jay TR; Casali BT; Bemiller SM; Puntambekar SS; von Saucken VE; Williams RY; Karlo JC; Moutinho M; Xu G; Ransohoff RM; Lamb BT; Landreth GE
Mol Neurodegener; 2018 Jun; 13(1):29. PubMed ID: 29859094
[TBL] [Abstract][Full Text] [Related]
17. Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer's disease.
Claes C; Danhash EP; Hasselmann J; Chadarevian JP; Shabestari SK; England WE; Lim TE; Hidalgo JLS; Spitale RC; Davtyan H; Blurton-Jones M
Mol Neurodegener; 2021 Jul; 16(1):50. PubMed ID: 34301296
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2.
Sudom A; Talreja S; Danao J; Bragg E; Kegel R; Min X; Richardson J; Zhang Z; Sharkov N; Marcora E; Thibault S; Bradley J; Wood S; Lim AC; Chen H; Wang S; Foltz IN; Sambashivan S; Wang Z
J Biol Chem; 2018 Aug; 293(32):12634-12646. PubMed ID: 29794134
[TBL] [Abstract][Full Text] [Related]
19. IPSC-Derived Neuronal Cultures Carrying the Alzheimer's Disease Associated
Martins S; Müller-Schiffmann A; Erichsen L; Bohndorf M; Wruck W; Sleegers K; Van Broeckhoven C; Korth C; Adjaye J
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630447
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease-associated R47H TREM2 increases, but wild-type TREM2 decreases, microglial phagocytosis of synaptosomes and neuronal loss.
Popescu AS; Butler CA; Allendorf DH; Piers TM; Mallach A; Roewe J; Reinhardt P; Cinti A; Redaelli L; Boudesco C; Pradier L; Pocock JM; Thornton P; Brown GC
Glia; 2023 Apr; 71(4):974-990. PubMed ID: 36480007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
